Mather K, DeGrado T
Biochim Biophys Acta. 2016; 1861(10):1535-43.
PMID: 26923433
PMC: 5141514.
DOI: 10.1016/j.bbalip.2016.02.019.
Kisrieva-Ware Z, Coggan A, Sharp T, Dence C, Gropler R, Herrero P
J Nucl Cardiol. 2009; 16(3):411-21.
PMID: 19212800
PMC: 2854568.
DOI: 10.1007/s12350-009-9051-7.
Murphy E, Rosenberger T, Patrick C, Rapoport S
Lipids. 2000; 35(8):891-8.
PMID: 10984112
DOI: 10.1007/s11745-000-0598-7.
Tamaki N, Fujibayashi Y, Magata Y, Yonekura Y, Konishi J
J Nucl Cardiol. 1995; 2(3):256-66.
PMID: 9420796
DOI: 10.1016/s1071-3581(05)80063-7.
Strauss H
J Nucl Cardiol. 1995; 2(1):92-3.
PMID: 9420770
DOI: 10.1016/s1071-3581(05)80017-0.
Cardiac metabolism: a technical spectrum of modalities including positron emission tomography, single-photon emission computed tomography, and magnetic resonance spectroscopy.
Valkema R, van Eck-Smit B, van der Wall E
J Nucl Cardiol. 1994; 1(6):546-60.
PMID: 9420749
DOI: 10.1007/BF02939978.
The use of iodinated free fatty acids for assessing fatty acid metabolism.
Tamaki N, Kawamoto M
J Nucl Cardiol. 1994; 1(2 Pt 2):S72-8.
PMID: 9420701
DOI: 10.1007/BF02940072.
Assessment of myocardial fatty acid metabolism with 1-11C-palmitate.
Geltman E
J Nucl Cardiol. 1994; 1(2 Pt 2):S15-22.
PMID: 9420693
DOI: 10.1007/BF02940064.
Impaired myocardial fatty acid metabolism detected by 123I-BMIPP in patients with unstable angina pectoris: comparison with perfusion imaging by 99mTc-sestamibi.
Takeishi Y, SUKEKAWA H, Saito H, Nishimura S, Shibu T, Sasaki Y
Ann Nucl Med. 1995; 9(3):125-30.
PMID: 8534584
DOI: 10.1007/BF03165038.
Assessment of viability after myocardial infarction. Clinical relevance and methodological problems.
Fragasso G, Margonato A, Chierchia S
Int J Card Imaging. 1993; 9 Suppl 1:3-10.
PMID: 8409541
DOI: 10.1007/BF01143141.
Uridine: a marker of myocardial viability after coronary occlusion and reperfusion.
Yaoita H, Fischman A, Strauss H, Saito T, Sato E, Maruyama Y
Int J Card Imaging. 1993; 9(4):273-80.
PMID: 8133125
DOI: 10.1007/BF01137154.
Effects of amino acids on substrate selection, anaplerosis, and left ventricular function in the ischemic reperfused rat heart.
Jessen M, Kovarik T, Jeffrey F, Sherry A, Storey C, Chao R
J Clin Invest. 1993; 92(2):831-9.
PMID: 8102382
PMC: 294921.
DOI: 10.1172/JCI116657.
The use of 123I-labeled heptadecanoic acid (HDA) as metabolic tracer: preliminary report.
Dudczak R, Kletter K, FRISCHAUF H, Losert U, Angelberger P, Schmoliner R
Eur J Nucl Med. 1984; 9(2):81-5.
PMID: 6368234
DOI: 10.1007/BF00254442.
omega-123I-hexadecanoic acid metabolic probe of cardiomyopathy.
Rabinovitch M, Kalff V, Allen R, Rosenthal A, Albers J, Das S
Eur J Nucl Med. 1985; 10(5-6):222-7.
PMID: 4039270
DOI: 10.1007/BF00254465.
Do iodinated fatty acids undergo a nonspecific deiodination in the myocardium?.
Cuchet P, Demaison L, Bontemps L, Keriel C, MATHIEU J, Pernin C
Eur J Nucl Med. 1985; 10(11-12):505-10.
PMID: 4029208
DOI: 10.1007/BF00252742.
Kinetics of rubidium-82 after coronary occlusion and reperfusion. Assessment of patency and viability in open-chested dogs.
Goldstein R
J Clin Invest. 1985; 75(4):1131-7.
PMID: 3988934
PMC: 425436.
DOI: 10.1172/JCI111807.
Myocardial imaging with radiolabeled free fatty acids: applications and limitations.
van der Wall E
Eur J Nucl Med. 1986; 12 Suppl:S11-5.
PMID: 3490370
DOI: 10.1007/BF00258095.
Cardiac nuclear medicine: positron emission tomography in clinical medicine.
Kaiser K, Feinendegen L
Eur J Nucl Med. 1988; 13(12):648-52.
PMID: 3282887
DOI: 10.1007/BF00256392.
Clinical applications of assessments of myocardial substrate utilization with positron emission tomography.
Bergmann S
Mol Cell Biochem. 1989; 88(1-2):201-9.
PMID: 2674665
DOI: 10.1007/BF00223445.
Regional rates of myocardial fatty acid metabolism: comparison with coronary angiography and ventriculography.
SCHAD N, Wagner R, Hallermeier J, Daus H, Vattimo A, Bertelli P
Eur J Nucl Med. 1990; 16(4-6):205-12.
PMID: 2351168
DOI: 10.1007/BF00842770.
